Missed Doses of Venous Thromboembolism Prophylaxis: a Growing Problem Without an Active Management Strategy

J Gen Intern Med. 2021 Feb;36(2):540-542. doi: 10.1007/s11606-020-06303-1. Epub 2020 Nov 2.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anticoagulants / adverse effects
  • Heparin
  • Humans
  • Risk Factors
  • Venous Thromboembolism* / epidemiology
  • Venous Thromboembolism* / prevention & control

Substances

  • Anticoagulants
  • Heparin